GL1X · GenesisL1 explorer

MolNFT v1 · #87542 · protein

Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1

4C4F · Dual specificity protein kinase ttk: “Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic kinase MPS1”. X-ray diffraction, 1 ligand (7CE), 1 pocket (best druggability 0.70). MolNFT v1 #87542 on…

PDB
4C4F
Type
protein
Length
255 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Dual specificity protein kinase ttk
EC
2.7.12.1
UniProt
P33981
Ligands
7CE
Pockets
1 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 39% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADual specificity protein kinase ttk (EC 2.7.12.1)protein25539% helix, 20% strandP33981

Ligands and binding sites

  • 7CE · N-(2-methoxyphenyl)-2-(1,3-oxazol-5-yl)-1H-pyrrolo[3,2-c]pyridin-6-amine · ligand · chains A
  • 7PE · 2-(2-(2-(2-(2-(2-ethoxyethoxy)ethoxy)ethoxy)ethoxy) ethoxy)ethanol · additive · 3 copies · chains A
  • EDO · 1,2-ethanediol · additive · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14780.700.80447PE, 7CE

Modifications

Observed in the structure: 1 modified (phosphorylation).

Compared structures

  • 4C4F · Structure-based design of orally bioavailable pyrrolopyridine inhibitors of the mitotic… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.